Clinical trials
Phase 3 Parkinsonian Disorders trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
16 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2010 | 1 |
| 2013 | 1 |
| 2014 | 5 |
| 2019 | 3 |
| 2020 | 3 |
| 2021 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 9 |
| Terminated | 3 |
| Unknown status | 2 |
| Not yet recruiting | 1 |
| Recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Adamas Pharmaceuticals, Inc. | 5 |
| AbbVie | 4 |
| Theravance Biopharma | 2 |
| Alseres Pharmaceuticals, Inc | 1 |
| Chang Gung Memorial Hospital | 1 |
| GE Healthcare | 1 |
| Ono Pharmaceutical Co., Ltd. | 1 |
| University College, London | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Parkinsonian Disorders | 16 |
| Parkinson Disease | 15 |
| Movement Disorders | 6 |
| Brain Diseases | 5 |
| Central Nervous System Diseases | 5 |
| Dyskinesias | 5 |
| Nervous System Diseases | 5 |
| Neurodegenerative Diseases | 5 |
| Multiple System Atrophy | 3 |
| Dizziness | 2 |
Trials
Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.